Today on DrugResearcher.com
 
Pfizer not alone in feeling the heat of California fires

J&J, Galapagos sign deal to search for arthritis 'Holy Grail'

Pfizer's cost-cutting focus no 'Kindler surprise'

Microfluidic stimulation of cells in culture

Merck KGaA pulls out of diabetes research

 
   
Related Industry News
 
WHO flu vaccine forecast an underestimate

Pharmaceutical manufacturing: people on the move

Global pact to fight fakes

Bentley to seperate its two businesses

 
 
Baxter Biopharma Solutions

Drug discovery

Breaking News on Drug Discovery
Daily  Wednesday 24 October 2007 Forward to a colleague

Product Brochure

Drop profiling for all aspects of drug developmentHigh precision optical profiling of liquid drops enhances drug discovery

Whether you are characterizing the uptake of active drug substances or controlling the quality of packaging materials, contact angle provides a quick, easy and sensitive measure of quality and cleanliness in research, QC and process control... Click Here

Access Full Stories



Pfizer not alone in feeling the heat of California fires
As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities... Read


J&J, Galapagos sign deal to search for arthritis 'Holy Grail'
Belgian biotech Galapagos has penned 'by far' its biggest ever deal, with Johnson & Johnson (J&J) committing an estimated €1bn to a joint arthritis research programme... Read


Pfizer's cost-cutting focus no 'Kindler surprise'
As it faces an increasingly uncertain financial future, Pfizer's reaffirmation that it plans to retain its focus on cutting costs, including outsourcing and offshoring, comes as no 'Kindler surprise', unlike the... Read


Microfluidic stimulation of cells in culture
US researchers have developed a fully automated microfluidic cell culture system that can control signalling agents in the extracellular media while maintaining cell viability for weeks... Read


Merck KGaA pulls out of diabetes research
In a shock announcement at its third quarter financial results, Merck KGaA has said it will stop its diabetes research and partner out any current programmes... Read


All News Headlines for:
October | September | August

Enjoy your work with Biohit pipettors!Product Overview

Have you got problems with aching hands in your lab?

Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here

Related Industry News



WHO flu vaccine forecast an underestimate
The forecast that 4.5 billion doses of pandemic influenza vaccine could be produced by 2010 is an underestimate, according to GlaxoSmithKline... Read


Pharmaceutical manufacturing: people on the move
Novartis, Immunosyn, Alpharma and Cegedim Dendrite have all had people on the move in the world of pharmaceutical manufacturing... Read


Global pact to fight fakes
A major new trade agreement aiming to combat counterfeiting has been proposed by representatives of a number of key markets, including the US, EU and several other countries worldwide... Read


Bentley to seperate its two businesses
Bentley Pharmaceuticals has announced it is planning to split in two in a bid to bolster its two business divisions... Read

Weekly Comment

'We are not anti-Asia' says EU chemicals body

There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read



Previous Headlines



New high-res structure will boost AIDS, cancer drug development
By solving the structure of a mammalian heat shock protein (HSP90) for the first time, a US scientist may have unlocked the door to better drugs to fight a myriad of diseases, such as AIDS, sepsis, certain cancers... Read


Sigma-Aldrich helps siRNA N-TER cells
Sigma-Aldrich has continued its push into siRNA delivery with the release of its N-TER nanoparticle system for hard-to-transfect cell lines... Read


Illumina halves the cost of miRNA expression profiling
Illumina has released a new microRNA (miRNA) assay for gene expression profiling at a cost that the company believes is less than half that of other commercially available systems... Read


Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead
Japan's Kirin Holdings, best-known in the West as a beer maker, will acquire a controlling stake in Kyowa Hakko, and thus get its hands on what Kyowa claims are 'the ultimate antibody warriors' against cancer... Read


Preclinical services news in brief
In this week's review of activity within the preclinical research services arena, new deals have emerged involving Cato Research, Genoway, Caliper Life Sciences and Rules-Based Medicine... Read

Technical / White Papers, Case studies, Web casts
Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com